DSM >>

Mr. Oscar Goddijn (43) graduated from Leiden University (The Netherlands) as a Molecular Biologist and obtained his PhD in 1992. In 1991 he moved to the company Mogen International NV, active in the area of genetic modification of crops were he occupied several positions.
After the acquisition by Zeneca and merger with Novartis into Syngenta in December 2000,
Mr. Goddijn was appointed as Managing Director of Syngenta Mogen.

He joined DSM in 2002 as Director Business Creation within DSM Venturing and Business Development. This business group hosted several early phase commercial activities and new ventures, developing into sustainable businesses. In this role he was responsible for new business opportunities in the area of Life Sciences. After announcing the new DSM Corporate Strategy, Vision 2010, a new Business Group was established, DSM Innovation Center, in which Mr. Goddijn is heading the Business Incubator, encompassing several emerging businesses.